<?xml version="1.0" encoding="UTF-8"?>
<p>Natural compounds are highly investigated for treating a broad spectrum of diseases and those manifesting antiviral activity might be of great use as adjuvants in COVID-19 therapies. For instance, Khaerunnisa et al. investigated the ability of some natural compounds such as kaempferol, quercetin, oleuropein, curcumin, catechin, and others to serve as potential inhibitor candidates for the SARS-CoV-2 main protease (Mpro). According to their paper, the affinity of kaempferol to Mpro is higher than that of other natural compounds and comparable to some FDA-approved drugs such as nelfinavir and lopinavir [
 <xref rid="B133-jcm-09-02084" ref-type="bibr">133</xref>].
</p>
